<DOC>
	<DOCNO>NCT01791868</DOCNO>
	<brief_summary>Study Hypothesis Generalized Convulsive Status Epilepticus ( GCSE ) medical emergency associate increased morbidity prolong length hospital stay . Only 50 % patient discharge hospital within first month GCSE . Recent Guidelines Experts highlight necessity improve efficiency first line anti-epileptic ( AE ) therapy . Intravenous Sodium Valproate ( SV ) might adjuvant AE drug recommend first line AEs . Intravenous SV available , well tolerate easily injectible also pharmacologic property reduce risk seizure relapse neuroprotective . However , efficacy intravenous adjuvant therapy GCSE never properly assess . Primary Purpose The primary purpose ass association intravenous Sodium Valproate recommend treatment Generalized Convulsive Status Epilepticus increase 20 % number living patient , discharge hospital day 15 .</brief_summary>
	<brief_title>Efficacy Study Intravenous Sodium Valproate Addition First Line Anti Epileptic Treatment Generalized Convulsive Status Epilepticus .</brief_title>
	<detailed_description>Patient admit Intensive Care Unit ( ICU ) Generalized Convulsive Status Epilepticus ( GCSE ) randomize fulfil inclusion criterion write informed consent obtain patient 's next kin . In clack close relative , patient could include accord French Health Code Case medical emergency . In situation , patient 's consent obtain soon possible According randomization arm , patient treat either intravenous sodium valproate ( 30 mg/kg 15 min 1 mg/kg/h 12 h ) intravenous placebo . All include patient benefit first-line anti epileptic drug symptomatic medical care , agreement Experts recommendation ( RFE 2009 ) . From day-1 day-15 , level consciousness ( Glasgow Coma Scale , Richmond Agitation Sedation Scale ) , delirium ( Confusion Assessment Method For Intensive Care Unit ) , reoccurrence seizure , vital sign , organ dysfunction ( Simplified Acute Physiology Score II , Sequential Organ Failure ) daily assess . At day 2 , preventive oral anti-epileptic drug prescribe neurologist , blind randomization . At Day 15 Day 30 , neurological status , cognitive function ( Mini Mental State Examination , Frontal Assessment Battery , Glasgow Outcome Scale ) , quality life ( SF36 ) assess neurologist , also aware randomization . The number patient alive discharged Hospital day 15 15th day assess . 300 patient GCSE randomize , 150 arm , 16 ICUs period 3 year .</detailed_description>
	<mesh_term>Status Epilepticus</mesh_term>
	<mesh_term>Valproic Acid</mesh_term>
	<mesh_term>Anticonvulsants</mesh_term>
	<criteria>Patient old 18 . Admitted participate ICU generalize convulsive status epilepticus ( GCSE ) i.e . persistent repeat generalized seizure without regain consciousness period five minute . provide duration treatment prior antiepileptic exceed : Six hour GCSE already control time inclusion ( = disappearance seizure regardless state consciousness ) Twentyfour hour GCSE persist recurrent . Written inform consent collect close relation family member patient . Otherwise , inclusion accord French Health Code case medical emergency . In case , write informed consent patient collect soon possible . absence close patient , patient may still include . consent prosecution collect Other type status epilepticus ( include atypical form ) occur onset anti epileptic . The length stay hospital expect occurrence GCSE &gt; 15 day . Expected Length stay ICU &lt; 12h . Hypoxicischemic encephalopathy . Pregnant woman , eclampsia check systematic pregnancy test . Preexisting chronic acute hepatitis , Cirrhosis B C. Family history acute hepatitis , especially drugrelated hepatitis Other sodium valproate Contraindications : Hypersensitivity sodium valproate derivative , acute chronic hepatitis ; personal family history severe hepatitis , particular drug ; hepatic porphyria , mefloquine hypericum taking . life expectancy expect â‰¤ 3 month . Patients already include another clinical trial GCSE . Non affiliation social health care . Patients tutelage . Patient already include protocol complete clinical trial .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>Generalized convulsive status epilepticus</keyword>
	<keyword>Sodium valproate</keyword>
	<keyword>Refractory status epilepticus</keyword>
	<keyword>Mortality</keyword>
	<keyword>Epilepsy</keyword>
	<keyword>Intensive Care Unit</keyword>
	<keyword>Neurological sequela</keyword>
	<keyword>Quality life</keyword>
	<keyword>Adult</keyword>
</DOC>